FSH clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
open to eligible people ages 18-65
A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Adult Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
at UCLA UCSD
Last updated: